| GTO ID | GTC3753 |
| Trial ID | NCT06252402 |
| Disease | HIV Infection |
| Altered gene | CMV |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CMV/HIV CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | A Pilot Study to Evaluate the Feasibility and Safety of Cytomegalovirus-Specific, Anti-HIV Chimeric Antigen Receptor (CMV-HIV CAR) T Cells in People Living With HIV |
| Year | 2024 |
| Country | United States |
| Company sponsor | City of Hope Medical Center |
| Other ID(s) | 22508 |
| Cohort 1 | |||||||||||
|
|||||||||||